BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 1346255)

  • 41. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
    Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M
    Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TP53 gene mutations and 17p deletions in human astrocytomas.
    Chung R; Whaley J; Kley N; Anderson K; Louis D; Menon A; Hettlich C; Freiman R; Hedley-Whyte ET; Martuza R
    Genes Chromosomes Cancer; 1991 Sep; 3(5):323-31. PubMed ID: 1686725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
    Jeng YM; Hsu HC
    Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens.
    Louis DN; Rubio MP; Correa KM; Gusella JF; von Deimling A
    J Neuropathol Exp Neurol; 1993 Sep; 52(5):507-15. PubMed ID: 8103086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas.
    Wu JK; Darras BT
    Neurol Res; 1992 Mar; 14(1):39-44. PubMed ID: 1351257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the p53 protein in a spectrum of astrocytic tumours.
    Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO
    J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic sub-types of human malignant astrocytoma correlate with survival.
    Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ
    Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors.
    Wu JK; Ye Z; Darras BT
    Neurosurgery; 1993 Nov; 33(5):824-30; discussion 830-1. PubMed ID: 7903434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular analysis of genomic abnormalities in human gliomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; PestaƱa A; Rey JA
    Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular genetic alterations in radiation-induced astrocytomas.
    Brat DJ; James CD; Jedlicka AE; Connolly DC; Chang E; Castellani RJ; Schmid M; Schiller M; Carson DA; Burger PC
    Am J Pathol; 1999 May; 154(5):1431-8. PubMed ID: 10329596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.
    Hu J; Pang JC; Tong CY; Lau B; Yin XL; Poon WS; Jiang CC; Zhou LF; Ng HK
    Br J Cancer; 2002 Jul; 87(2):218-24. PubMed ID: 12107846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S
    Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
    Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
    Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
    Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.
    Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P
    Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.